• Volume 7, October 2019

    How ADAPTABLE Study fits in the recent guidelines on use of aspirin in cardiovascular diseases

    On March 17, 2019, the American College of Cardiology and the American Heart Association
    jointly published recommendations based on recent studies on the use of aspirin to prevent cardiovascular diseases.

    For individuals who have ... Read more about this Newsletter

  • Volume 6, February 2019

    Top Lessons Learned from ADAPTABLE Patient Partners

    ADAPTABLE patient partners, also known as Adaptors, provide input to the study team at every critical step in the research process. Adaptors are passionate about patient-centered research and draw on their personal work and life experiences to improve the study participant experience ... Read more about this Newsletter

  • Volume 5, October/November 2018

    Every Participant Counts from Enrollment to Study Completion

    Equally important to enrollment of participants in a research study is retention. Retention is the number of patients who remain in the study until it is completed. Well-intentioned participants occasionally drop out early for a variety of reasons and, of course, ... Read more about this Newsletter

  • Volume 4, May 2018

    The Importance of Diversity in Clinical Research
    Despite what is known about how certain groups of people may respond differently to disease; traditionally, the majority of cardiovascular clinical research study participants are white men. Increasing diversity in clinical research studies is a priority for the Food and ... Read more about this Newsletter

  • Volume 3, February 2018

    Celebrating Your Heart and Heart-Health Awareness & American Heart Month.
    Heart disease is the leading cause of death for American women and men, responsible for one in four deaths in the U.S. According to the Centers for Disease Control and Prevention, someone in the U.S. has a ... Read more about this Newsletter

  • Volume 2, October 2017

    Better health outcomes for all when patients partner with researchers.
    This motto crafted by the Adaptors, ADAPTABLE’s patient partners, reflects how patient participation in research can help answer health questions that matter most to patients and their doctors. The Adaptors’ motto is part of the Hero’s Journey Art ... Read more about this Newsletter

  • Volume 1: Welcome, June 2017

    Thank you for your participation in the ADAPTABLE Study.

    Your involvement in this research study will help us to answer a simple, but extremely important question—what is the best aspirin dose (81 mg or 325 mg) for patients with heart disease? In addition to answering the aspirin-dose question, ... Read more about this Newsletter

tertiary sidebar container